Predicta Biosciences

About:

Predicta Biosciences uses multiomics and liquid biopsies in precision oncology to create innovative diagnostics and therapies.

Website: https://www.predictabiosciences.com

Top Investors: Engine Ventures, Illumina Ventures, BrightEdge - American Cancer Society, Time Partners Limited

Description:

Predicta Biosciences is a precision oncology firm that integrates multiomics and liquid biopsies to create diagnostic tools and therapies. They also have an in-house pipeline for novel immunotherapy targets in pre-clinical stages.

Total Funding Amount:

$5.2M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2023-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2024-07-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai